InvestorsHub Logo
Followers 18
Posts 1414
Boards Moderated 0
Alias Born 11/01/2018

Re: Gator328 post# 350736

Friday, 02/11/2022 1:29:53 AM

Friday, February 11, 2022 1:29:53 AM

Post# of 457721
Gator328

He’s fine for now. We have several trials in motion, minimal debt, minimal dilution and are starting to attract the attention of institutional investors.

Is he the right CEO for AVXL 5-10 years from now? Maybe, maybe not. His weakness is communication but that’s a skill that comes with experience. His PR mistakes don’t bother me as long as he learns from them and doesn’t repeat them.


Great assessment. Dr. Missling is a young man to accomplish what no man has done before in the CNS space. No company has done this to date. Never a CNS drug trial missed in this space by AVXL. Dr. Missling smart as anyone can tell. This company is worth $75 BilLION with current drug trial results and growing. AVXL cutting edge in the CNS space. imo of course.

Sign Me up for A2-73. Send it to my home. Thanks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News